EMEA

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

News

Catalent Opens Cell Therapy Facility in Belgium

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.

News

UK Votes to Remain Part of EMA

Topics • Chemistry

Helping Customers Meet Market Requirements

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Interview

Trade and Competitiveness

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

EMEA

Pharma Outlook 2025

Catalent Opens Cell Therapy Facility in Belgium

UK Votes to Remain Part of EMA

Helping Customers Meet Market Requirements

Top-Feature

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Siemens Joins the Global Impact Coalition

Interview

The UK Chemical Supply Chain

EMEA

Pharma Outlook 2025

Catalent Opens Cell Therapy Facility in Belgium

UK Votes to Remain Part of EMA

Helping Customers Meet Market Requirements

Top-Feature

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Siemens Joins the Global Impact Coalition

Interview

The UK Chemical Supply Chain

Newsletter & e-edition